EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion

Tsuyoshi Kadomatsu iD, Chiaki Hara, Ryoma Kurahashi, Haruki Horiguchi, Jun Morinaga, Keishi Miyata, Sohtaro Kurano, Hisashi Kanemaru, Satoshi Fukushima, Kimi Araki, Masaya Baba, W Marston Linehan und 2 weitere

Molecular Oncology · 2023-12 · 17 (12) · 2637-2658

DOI: 10.1002/1878-0261.13490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 07.08.2023. Verfasst von Tsuyoshi Kadomatsu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, Kato Memorial Bioscience Foundation, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss or downregulation of major histocompatibility complex class I (MHC‐I) contributes to tumor immune evasion. We previously demonstrated that angiopoietin‐like protein 2 (ANGPTL2) promotes tumor progression using a Xp11.2 translocation renal cell carcinoma (tRCC) mouse model. However, molecular mechanisms underlying ANGPTL2 tumor‐promoting activity in the tRCC model remained unclear. Here, we report that ANGPTL2 deficiency in renal tubular epithelial cells slows tumor progression in the tRCC mouse model and promotes activated CD8 + T‐cell infiltration of kidney tissues. We also found that Angptl2 ‐deficient tumor cells show enhanced interferon γ‐induced expression of MHC‐I and increased susceptibility to CD8 + T‐cell‐mediated anti‐tumor immune responses. Moreover, we provide evidence that the ANGPTL2‐α5β1 integrin pathway accelerates polycomb repressive complex 2‐mediated repression of MHC‐I expression in tumor cells. These findings suggest that ANGPTL2 signaling in tumor cells contributes to tumor immune evasion and that suppressing that signaling in tumor cells could serve as a potential strategy to facilitate tumor elimination by T‐cell‐mediated anti‐tumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAnimalsMiceAngiopoietin-Like Protein 2Angiopoietin-like ProteinsTumor EscapeEpigenetic RepressionHistocompatibility Antigens Class IDisease Models, Animal

Stichwörter der Autor:innen

ANGPTL2H3K27me3MHC-IPRC2tumor immune evasion

Substanzen

Angiopoietin-Like Protein 2Angiopoietin-like ProteinsHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Department of Aging and Geriatric Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Department of Dermatology and Plastic Surgery, Graduate School of Medical Sciences, Kumamoto University, Japan.

ORCID-Profile: Tsuyoshi Kadomatsu, Yuichi Oike

Förderung

  • Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
  • Kato Memorial Bioscience Foundation
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Kadomatsu, T., Hara, C., Kurahashi, R., Horiguchi, H., Morinaga, J., Miyata, K., Kurano, S., Kanemaru, H., Fukushima, S., Araki, K., Baba, M., Linehan, W. M., Kamba, T., & Oike, Y. (2023). ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion. Molecular Oncology, 17(12), 2637-2658. https://doi.org/10.1002/1878-0261.13490

Vancouver

Kadomatsu T, Hara C, Kurahashi R, Horiguchi H, Morinaga J, Miyata K, et al. ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion. Molecular Oncology. 2023;17(12):2637-2658. doi:10.1002/1878-0261.13490

BibTeX
@article{Kadomatsu2023,
  author = {Kadomatsu, Tsuyoshi and Hara, Chiaki and Kurahashi, Ryoma and Horiguchi, Haruki and Morinaga, Jun and Miyata, Keishi and Kurano, Sohtaro and Kanemaru, Hisashi and Fukushima, Satoshi and Araki, Kimi and Baba, Masaya and Linehan, W Marston and Kamba, Tomomi and Oike, Yuichi},
  title = {ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion},
  journal = {Molecular Oncology},
  year = {2023},
  volume = {17},
  number = {12},
  pages = {2637--2658},
  doi = {10.1002/1878-0261.13490}
}
Kostenlos starten →